Protection of ischemic myocardium in experimental animals and in man: a review.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000818:Animals; D002331:Carnitine / Q000627:therapeutic use; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000097:blood; D003999:Dichloroacetic Acid / Q000627:therapeutic use; D004070:Digitalis; D004285:Dogs; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D006821:Hyaluronoglucosaminidase / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D007423:Intra-Aortic Balloon Pumping; D009203:Myocardial Infarction / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D005996:Nitroglycerin / Q000627:therapeutic use; D010101:Oxygen Consumption; D010477:Perfusion; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011188:Potassium / Q000627:therapeutic use; D011773:Pyruvates / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000960:Hypolipidemic Agents; D007328:Insulin; D011773:Pyruvates; C030396:glucose-insulin-potassium cardioplegic solution; D003999:Dichloroacetic Acid; D003402:Creatine Kinase; D006821:Hyaluronoglucosaminidase; D005996:Nitroglycerin; D005947:Glucose; D011188:Potassium; D002331:Carnitine